Department of Chemistry, University of Kentucky, Lexington, KY.
Photochem Photobiol. 2017 Oct;93(5):1326-1328. doi: 10.1111/php.12796. Epub 2017 Aug 7.
This article is a highlight of the paper by Lazic et al. in this issue of Photochemistry and Photobiology, https://doi.org/10.1111/php.12767. It describes the validation of osmium coordination complexes as photosensitizers for photodynamic therapy, with very promising in vivo results that demonstrate radical improvements in survival following irradiation with visible (635 nm) or near-IR (NIR; 808 nm) light. An unusual feature in the study is that the different complexes exhibit disparate photophysical and photobiological characteristics, despite sharing common structural motifs. These findings raise hopes for the development of novel photosensitizers that overcome the limitations of current commercially available systems for PDT, but also raise questions regarding the most efficacious biological mechanisms of action for this treatment modality.
这篇文章是 Lazic 等人在本期《光化学与光生物学》中发表的论文的重点介绍,https://doi.org/10.1111/php.12767。它描述了锇配位配合物作为光动力治疗的光敏剂的验证,具有非常有前途的体内结果,表明在可见光(635nm)或近红外(NIR;808nm)光照射下,生存率得到了显著提高。该研究的一个不寻常特征是,尽管具有共同的结构基序,但不同的配合物表现出不同的光物理和光生物特性。这些发现为开发克服当前 PDT 市售系统局限性的新型光敏剂带来了希望,但也对这种治疗方式最有效的生物学作用机制提出了疑问。